XFOR — X4 PHARMACEUTICALS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 94 家机构在其最新 13F 申报中持有 XFOR(X4 PHARMACEUTICALS INC),合计申报市值 $470.66M,对应 100.85M 股。按股数计算较上季度增持 6.5%(+5.85M 股),申报市值环比上升 20.4%。持仓集中度较高:前五大持有人占申报市值的 40.3%,前十大的集中度为 65.9%。
与上一季度相比,38 家新建仓位、22 家加仓、12 家减仓、28 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
X4 PHARMACEUTICALS INC(XFOR)的主要机构持有人包括 Bain Capital Life Sciences Investors, LLC、PERCEPTIVE ADVISORS LLC、Saturn V Capital Management LP,按 13F 申报市值在本页 222 家持有人中排名居前。
XFOR 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 54 | 40.94M | $118.72M | +6.0% |
| Q2 2026 | 94 | 100.85M | $470.66M | +6.5% |
| Q1 2026 | 84 | 95.18M | $393.33M | +8.8% |
| Q4 2025 | 79 | 89.55M | $358.19M | +169.8% |
| Q3 2025 | 42 | 16.35M | $55.91M | +192.5% |
| Q2 2025 | 52 | 2.91M | $5.52M | -96.8% |
| Q1 2025 | 95 | 97.18M | $23.14M | +0.7% |
| Q4 2024 | 86 | 97.20M | $71.31M | +1.3% |
表内 8 个季度中,机构持股合计减少 58%(Q4 2024 → Q3 2026);单季变动最大的是 Q3 2025(+192.5%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 11.00M | $31.89M | 0.00% | 增持 | |
| 5.85M | $16.98M | 0.00% | 增持 | |
| 5.49M | $15.92M | 0.00% | 减持 | |
| 3.72M | $10.80M | 8.15% | 持有 | |
| 3.56M | $10.32M | 0.00% | 减持 | |
| 2.45M | $7.10M | 0.33% | 持有 | |
| 2.06M | $5.98M | 0.28% | 增持 | |
| 2.05M | $5.94M | 0.00% | 减持 | |
| 1.73M | $5.02M | 0.00% | 增持 | |
| 572.11K | $1.66M | 0.00% | 增持 | |
| 512.81K | $1.49M | 0.00% | 减持 | |
| 213.26K | $618.45K | 0.00% | 增持 | |
| 204.99K | $594.47K | 0.00% | 增持 | |
| 150.00K | $435.00K | 0.33% | 减持 | |
| 130.42K | $378.23K | 0.00% | 增持 | |
| 117.23K | $339.97K | 0.00% | 增持 | |
| 115.52K | $335.02K | 0.00% | 增持 | |
| 113.74K | $329.83K | 0.00% | 增持 | |
| 111.06K | $322.06K | 0.00% | 增持 | |
| 94.98K | $275.45K | 0.00% | 持有 | |
| 83.49K | $242.12K | 0.00% | 增持 | |
| 70.15K | $203.43K | 0.06% | 新进 | |
| 68.98K | $200.03K | 0.00% | 减持 | |
| 68.60K | $198.94K | 0.00% | 新进 | |
| 49.25K | $142.83K | 0.00% | 减持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 8.95M | $35.80M | 31.57% | 新进 | |
| 8.50M | $34.00M | 0.00% | 新进 | |
| 8.21M | $32.83M | 0.00% | 增持 | |
| 7.97M | $31.87M | 2.44% | 增持 | |
| 6.31M | $25.26M | 0.48% | 新进 | |
| 5.80M | $23.20M | 4.26% | 新进 | |
| 5.01M | $20.05M | 0.36% | 增持 | |
| 3.72M | $14.89M | 14.73% | 新进 | |
| 3.42M | $13.69M | 0.00% | 增持 | |
| 3.37M | $13.48M | 0.46% | 新进 | |
| 3.23M | $12.93M | 0.66% | 增持 | |
| 2.68M | $10.73M | 0.04% | 新进 | |
| 2.61M | $10.42M | 4.17% | 增持 | |
| 2.57M | $10.29M | 2.54% | 新进 | |
| 2.45M | $9.80M | 0.49% | 增持 | |
| 2.23M | $8.93M | 0.30% | 持有 | |
| 1.96M | $7.84M | 0.81% | 新进 | |
| 1.50M | $6.00M | 0.18% | 新进 | |
| 1.23M | $4.91M | 0.00% | 增持 | |
| 1.00M | $4.00M | 0.02% | 新进 | |
| 940.45K | $3.76M | 0.00% | 增持 | |
| 898.47K | $3.59M | 0.70% | 增持 | |
| 831.89K | $3.33M | 0.00% | 新进 | |
| 808.15K | $3.23M | 0.01% | 增持 | |
| 593.57K | $2.37M | 1.83% | 减持 |
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 2.44M | $8.33M | 0.55% | 增持 | |
| 2.23M | $7.64M | 0.42% | 增持 | |
| 2.23M | $7.64M | 0.31% | 新进 | |
| 2.23M | $7.62M | 0.30% | 新进 | |
| 1.54M | $5.28M | 2.20% | 新进 | |
| 1.12M | $3.84M | 0.11% | 新进 | |
| 1.06M | $3.61M | 2.94% | 新进 | |
| 933.33K | $3.19M | 0.42% | 增持 | |
| 555.41K | $1.90M | 0.49% | 新进 | |
| 410.49K | $1.40M | 0.00% | 增持 | |
| 343.96K | $1.18M | 0.03% | 新进 | |
| 273.35K | $934.86K | 0.47% | 增持 | |
| 180.85K | $618.51K | 0.07% | 增持 | |
| 159.84K | $546.63K | 0.00% | 增持 | |
| 127.90K | $437.42K | 0.00% | 增持 | |
| 95.33K | $326.02K | 0.10% | 新进 | |
| 79.66K | $272.47K | 0.00% | 增持 | |
| 64.80K | $221.60K | 0.00% | 减持 | |
| 64.80K | $221.60K | 0.00% | 减持 | |
| 61.93K | $211.81K | 0.00% | 减持 | |
| 38.73K | $132.47K | 0.00% | 增持 | |
| 21.67K | $74.10K | 0.00% | 持有 | |
| 19.30K | $66.02K | 0.00% | 减持 | |
| 19.18K | $65.58K | 0.00% | 增持 | |
| 13.87K | $47.43K | 0.00% | 新进 |
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 563.86K | $1.07M | 0.13% | 减持 | |
| 499.56K | $949.16K | 0.07% | 减持 | |
| 233.33K | $443.33K | 0.06% | 减持 | |
| 231.89K | $440.60K | 0.00% | 减持 | |
| 179.23K | $340.53K | 0.00% | 减持 | |
| 153.73K | $292.09K | 0.19% | 减持 | |
| 132.72K | $252.00K | 0.02% | 新进 | |
| 109.96K | $208.92K | 0.00% | 减持 | |
| 97.34K | $184.95K | 0.00% | 增持 | |
| 80.32K | $152.60K | 0.00% | 增持 | |
| 80.00K | $152.00K | 0.00% | 减持 | |
| 78.06K | $148.32K | 0.00% | 减持 | |
| 78.06K | $148.32K | 0.00% | 新进 | |
| 60.05K | $114.10K | 0.01% | 减持 | |
| 49.15K | $93.40K | 0.00% | 减持 | |
| 38.98K | $74.07K | 0.00% | 新进 | |
| 34.82K | $66.16K | 0.00% | 减持 | |
| 26.38K | $50.12K | 0.00% | 减持 | |
| 26.38K | $50.12K | 0.00% | 新进 | |
| 21.67K | $41.17K | 0.00% | 减持 | |
| 18.86K | $35.84K | 0.00% | 减持 | |
| 17.37K | $32.99K | 0.00% | 减持 | |
| 15.53K | $29.52K | 0.00% | 减持 | |
| 12.59K | $24.00K | 0.00% | 减持 | |
| 11.26K | $21.39K | 0.00% | 减持 |
新建仓(Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 2.10M 股 · $9.80M
- VANGUARD PORTFOLIO MANAGEMENT LLC 542.13K 股 · $2.53M
- Verdad Advisers, LP 352.09K 股 · $1.64M
- Sixth Street Partners Management Company, L.P. 263.26K 股 · $1.23M
- Caption Management, LLC 250.00K 股 · $1.17M
- BNY Mellon 196.34K 股 · $916.91K
- Nuveen, LLC 107.39K 股 · $501.51K
- ALPS ADVISORS INC 95.73K 股 · $447.04K
- RHUMBLINE ADVISERS 95.08K 股 · $444.02K
- Deutsche Bank AG 78.89K 股 · $368.39K
- GSA CAPITAL PARTNERS LLP 76.31K 股 · $356.00K
- AMERICAN CENTURY COMPANIES INC 74.80K 股 · $349.29K
完全清仓(较上季)
- Millennium Management 卖出 1.21M 股 · $5.00M
- MILLENNIUM MANAGEMENT LLC 卖出 1.21M 股 · $5.00M
- STEMPOINT CAPITAL LP 卖出 850.74K 股 · $3.51M
- STATE STREET CORP 卖出 403.53K 股 · $1.67M
- Marshall Wace 卖出 336.83K 股 · $1.39M
- ACORN CAPITAL ADVISORS, LLC 卖出 234.04K 股 · $966.58K
- Qube Research & Technologies Ltd 卖出 218.95K 股 · $904.28K
- Pale Fire Capital SE 卖出 167.59K 股 · $692.15K
- Brevan Howard Capital Management LP 卖出 127.32K 股 · $525.84K
- Dynamic Technology Lab Private Ltd 卖出 36.22K 股 · $384.67K
- OMERS ADMINISTRATION Corp 卖出 57.30K 股 · $236.65K
- Hudson Bay Capital Management LP 卖出 50.29K 股 · $207.69K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley | 11.00M | 9.46M | 9.47M | 8.21M | 3.73K | 10.92K | 570.01K | 550.50K | 490.66K | 229.34K | 1.41M | 401.37K | 241.74K | — | — | — | — | — | — | — |
| BlackRock Inc | 5.85M | 5.55M | 1.21M | 1.23M | 61.93K | 179.23K | 11.43M | 11.06M | 11.21M | — | — | — | — | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 5.49M | 8.32M | 8.10M | 8.50M | — | 1.70K | 41.12K | 4.70K | 11.14K | 3.60K | 2.53K | 739 | 1.58K | — | — | — | — | — | — | — |
| Kalehua Capital Management LLC | 3.72M | 3.72M | 3.72M | 3.72M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.56M | 3.72M | 3.50M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Nantahala Capital Management, LLC | 2.45M | 2.45M | 2.45M | 2.45M | 2.23M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Affinity Asset Advisors, LLC | 2.06M | 145.00K | 145.00K | 145.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 2.05M | 2.10M | 939.73K | 940.45K | 79.66K | 49.15K | 3.62M | 3.50M | 3.45M | 3.52M | 2.95M | 2.80M | 2.64M | — | — | 587.52K | — | — | — | — |
| STATE STREET CORP | 1.73M | — | 403.53K | 198.23K | 38.73K | 15.53K | 3.06M | 3.06M | 2.95M | 2.76M | 2.52M | 2.43M | 2.38M | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 572.11K | 542.13K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 512.81K | 572.04K | 480.73K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Russell Investments Group, Ltd. | 213.26K | 7.18K | 729 | 729 | 729 | 9.73K | — | — | — | 1.90K | — | — | — | — | — | — | — | — | — | — |
| BNY Mellon | 204.99K | 196.34K | — | — | — | — | 344.75K | 344.75K | 344.75K | 469.37K | 335.97K | 345.95K | 474.69K | — | — | — | — | — | — | — |
| Stonepine Capital Management, LLC | 150.00K | 224.99K | 335.31K | 593.57K | 1.06M | — | — | — | — | — | — | — | 5.27M | — | — | — | — | — | — | — |
| ALPS ADVISORS INC | 130.42K | 95.73K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Invesco Ltd | 117.23K | 96.77K | 19.97K | — | — | — | 58.19K | 62.07K | 123.78K | 98.58K | 98.62K | 96.43K | 81.03K | — | — | — | — | — | — | — |
| Renaissance Technologies | 115.52K | 18.10K | — | — | 19.18K | 17.37K | 20.10K | — | — | — | — | — | — | — | 10.09K | 94.79K | 242.19K | 216.19K | 173.09K | 137.29K |
| AMERICAN CENTURY COMPANIES INC | 113.74K | 74.80K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Nuveen, LLC | 111.06K | 107.39K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| RHUMBLINE ADVISERS | 94.98K | 95.08K | — | — | — | — | 188.41K | 178.72K | 178.48K | 187.25K | 163.41K | 160.37K | 160.37K | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold XFOR?
As of 2026-Q2, 94 institutional funds reported holding XFOR (X4 PHARMACEUTICALS INC) in SEC 13F filings, with a combined reported value of $470.66M.
How many shares of XFOR do institutions own?
13F filers reported 100.85M shares of XFOR, worth $470.66M in aggregate at the end of 2026-Q2.
Is institutional ownership of XFOR rising or falling?
Share counts moved +6.5% versus the prior quarter — accumulation.
Who are the top institutional holders of XFOR?
The largest 13F holders are Bain Capital Life Sciences Investors, LLC, PERCEPTIVE ADVISORS LLC, Saturn V Capital Management LP, Empery Asset Management, LP, Morgan Stanley; the top 25 are ranked at the top of this page.
Who are the major shareholders of X4 PHARMACEUTICALS INC?
The major shareholders of X4 PHARMACEUTICALS INC (XFOR) by reported 13F value are Bain Capital Life Sciences Investors, LLC, PERCEPTIVE ADVISORS LLC, Saturn V Capital Management LP, Empery Asset Management, LP, Morgan Stanley, among 222 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.